Developing ADCs in the Post-DS-8201 Era: Future Perspectives

Developing ADCs in the Post-DS-8201 Era: Future Perspectives

The 4th Global Biopharmaceutical Frontier Technology Conference and Exhibition is Open for Registration! The story of the “magic bullet” ADC has clearly not reached its final chapter. With the advent of DS-8201, the global ADC market has become exceptionally vibrant, entering a period of rapid growth. The market’s enthusiasm for ADCs is evident from the … Read more

ADC Case Study: Overcoming Metastatic Breast Cancer

ADC Case Study: Overcoming Metastatic Breast Cancer

Expert Commentary Professor Yuan Zhongyu Department of Internal Medicine, Sun Yat-sen University Cancer Prevention and Treatment Center Chief Physician, MD, Doctoral Supervisor Engaged in clinical and research work on breast cancer for many years, has presided over and participated in over 20 clinical studies, involved in several research projects such as the National 863 Program … Read more

Case Sharing of ADC: A HER2-Positive Breast Cancer Case

Case Sharing of ADC: A HER2-Positive Breast Cancer Case

Expert Commentary Professor Feng Jifeng Chief Physician, Professor, Doctoral Supervisor Secretary of the Party Committee, Jiangsu Provincial Cancer Hospital/Nanjing Medical University Affiliated Cancer Hospital Member of the Expert Committee on Rational Drug Use, National Health Commission Council Member of the Chinese Medical Association, Member of the Internal Medicine Group of the Oncology Branch Vice President … Read more

HER2 Low-Positive Breast Cancer: A Potential New Subtype for Precision Treatment

HER2 Low-Positive Breast Cancer: A Potential New Subtype for Precision Treatment

Author: Cornflower This article is published with the author’s permission by Yiliao Tong. Please do not reproduce without authorization. Human epidermal growth factor receptor 2 (HER2) positive breast cancer is a highly aggressive molecular subtype with poor prognosis. The advent of anti-HER2 targeted therapies has significantly improved its prognosis. Currently, international standards generally consider that … Read more

Exciting News: DS-8201 Brings New Hope for HER2 Positive Breast Cancer Patients!

Exciting News: DS-8201 Brings New Hope for HER2 Positive Breast Cancer Patients!

With the advancement of breast cancer treatment, there are increasingly more life-saving drugs available for patients. The emergence of new treatment methods is like a relay race, passing on the hope of life, even in the face of recurrence and metastasis, it is no longer a dead end. In the past, anti-HER2 treatments saved countless … Read more

Case Report: HER2 Negative to Positive Conversion in Breast Cancer Re-biopsy?! Benefits of DS-8201 Treatment

Case Report: HER2 Negative to Positive Conversion in Breast Cancer Re-biopsy?! Benefits of DS-8201 Treatment

Open the public account and set it as a “star”. Follow us to learn more about cancer information!~ Breast Cancer In recent years, the treatment of breast cancer has been influenced by the practice of precision oncology, requiring personalized medical care based on specific tumor characteristics. The treatment of breast cancer primarily depends on the … Read more